Physician
Psychiatry
Dr. Joseph K. Belanoff, MD
|
|
Give Review
Joseph Belanoff is an expert in the field of Psychiatry. He studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical university. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine Joseph Belanoff has written publications. He has 26 publications published with PubMed. The lastest publication is: 'Treatment of psychotic depression.'
Publications
- 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
- Corticosteroids and cognition.
- Cortisol activity and cognitive changes in psychotic major depression.
- Rapid reversal of psychotic depression using mifepristone.
- Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone.
- An open label trial of C-1073 (mifepristone) for psychotic major depression.
- A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction.
- Mifepristone treatment of olanzapine-induced weight gain in healthy men.
- Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.
- Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain.
- Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.
- Efficacy and safety of mifepristone for the treatment of psychotic depression.
- Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice.
- A randomized trial of the efficacy of group therapy in changing viral load and CD4 counts in individuals living with HIV infection.
- The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
- Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
- 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists.
- Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
- 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity.
- Treatment of psychotic depression.
- C-1073 (mifepristone) in the adjunctive treatment of Alzheimer''s disease.
- Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).
- The use of mifepristone in the treatment of neuropsychiatric disorders.
- Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.
- Gender differences, but no racial group differences, in self-reported psychiatric symptoms in adolescents.
Schools
Columbia University College of Physicians And Surgeons
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Stanford University -
Columbia University College of Physicians & Surgeons
Helpful Reviews
Similar Doctors
|
|
Dr. Carlos C. Greaves, MD |
|
|
Dr. Steven C. Bagley, MD |
|
|
Dr. Norman Dishotsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth M. Gebis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nadia Haddad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Agnieszka Kalinowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael F. Haberecht, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alka N. Mathur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven S. Storage, MD |